FridayJul 23, 2021 9:00 am

Test Results Boost Lexaria Bioscience Corp. (NASDAQ: LEXX) Potential in Enhancing Antiviral Drugs

Lexaria Bioscience has completed a study conducted by Canada’s National Research Council for the use of its DehydraTECH IP with five drugs known to target the main protease associated with SARS-CoV-2 infection, including remdesivir The SARS-CoV-2 infection is the underlying force behind the COVID-19 pandemic that has killed millions of people during the past year and currently has begun trending toward a rising infection rate again DehydraTECH technology helps drugs gain better bioavailability through quick and effective introduction into patients’ bloodstreams using oral administration as opposed to injections The recent study results demonstrate that DehydraTECH-processed remdesivir, ebastine, bepridil, rupintrivir, and…

Continue Reading

ThursdayJul 22, 2021 10:00 am

Hero Technologies Inc. (HENC) in Position to Contribute to $92B Economic Boost Projected to Come from Cannabis Sector

A recent analysis reports that the cannabis sector is projected to add approximately $92 billion to the general U.S. economy this year From jobs to tax revenue to commercial real estate, the marijuana industry has a growing impact on broader U.S. economy Hero Technologies is planning expansion in cultivation and dispensary operations Companies operating in the cannabis space in the United States sometimes have to deal with negative stereotypes and news, but this week, cannabis headlines focused on the positive. A recent MJBizFactbook analysis reports that the cannabis sector is projected to add approximately $92 billion to the general U.S.…

Continue Reading

WednesdayJul 21, 2021 9:00 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has companies such as BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) anticipating increased numbers as well (https://cnw.fm/O7FOa). A leader in the space, BevCanna is looking to leverage its position in the growing market as a white label manufacturer of infused-cannabis beverage brands. According to a…

Continue Reading

TuesdayJul 20, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Exec Releases Update on Entertainment Division

GTVH has new office space to develop, manage, market all company ventures Lavish Entertainment’s goal is to “throw the most epic raves in the world” Founder notes spinoff of two companies slated to happen after GTVH completes audited financials Golden Triangle Ventures (OTC: GTVH) has announced key milestones reached by its entertainment division, which owns Lavish Entertainment Inc. and is doing business as EpicRaves. GTVH president Steffan Dalsgaard provided a summary of the division’s impressive progress in a mid-year letter to shareholders (https://cnw.fm/RVG5u).  In the letter, Dalsgaard noted significant progress made by the company’s entertainment division, including moving into new…

Continue Reading

TuesdayJul 20, 2021 9:00 am

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

Science continues to substantiate use of cannabis for pain relief, epileptic seizure control Research suggests strains with optimized cannabinoid profiles are more effective  PACR produces premium top-quality strains cultivated using genetics-first approach to optimize cannabinoid profiles Genetic cultivation techniques allow selection for specific growing environments, maximum yields  With a growing list of use cases spanning pain relief to seizure control, the medicinal use of cannabis goes back thousands of years (https://cnw.fm/GvpWP). Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian cannabis company, leverages a genetics-focused approach to producing premium-quality strains with optimum cannabinoid profiles that are prized among…

Continue Reading

MondayJul 19, 2021 11:24 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Partners with Agora Internet Relations Corp. for Its Marketing and Advertising

XPhyto partners with AGORA t to grow its brand and overall market share The agreement entails shares issued to AGORA on August 21, 2021 and December 31, 2021 at a price of $2.12 per share, subject to a hold period that ends on October 18, 2021 AGORA is known for its online marketing, conferences, broadcasting and investor relations services Its clients include CardioComm Solutions, Good Life Networks, Northern Sphere, Grizzly Discoveries and IntellaEquity Inc., among others XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) just announced that it is following through with its advertising agreement with AGORA Internet Relations Corp…

Continue Reading

MondayJul 19, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Working to Develop, Commercialize First-of-Its-Kind Technology

GTVH, HyFrontier Technologies working together to offer a patent-pending hydrogen and oxygen delivery system for agriculture. Company has seen recent developments that could significantly benefit the entire agricultural industry. Duplicating enhanced-growth thunderstorms cause can reduce need for crop rotations, helping millions of people avoid starvation. A little more than a month after announcing its formal purchase agreement with HyFrontier Technologies (https://cnw.fm/MYPN3), Golden Triangle Ventures (OTC: GTVH) is making good on its commitment to pursue ventures in the technology sector to provide advanced technology for the modern era. GTVH and HyFrontier Technologies are working together to offer a patent-pending, first-of-its-kind hydrogen…

Continue Reading

FridayJul 16, 2021 9:30 am

New Patent Expands Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Suite to 20 Granted Worldwide (First in Japan)

Drug delivery platform developer Lexaria Bioscience recently received its 20th patent — granted in Japan for beverages with lipophilic active agents The active agents include non-psychoactive cannabinoids and over-the-counter NSAIDS such as ibuprofen and aspirin that target pain and inflammation Lexaria’s DehydraTECH platform transforms drugs into a powder or liquid form that maintains the drug’s efficacy and allows it to be assimilated by the body more rapidly than normal oral ingestion of pills The company will also announce the latest results from six key R&D projects focusing on concentration levels, tolerability and avoidance of incidental new molecular entities (“NMEs”) soon…

Continue Reading

ThursdayJul 15, 2021 11:23 am

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Portfolio Rising Amid Consolidation Trend in CBD Market Sector

HempFusion Wellness is raising its profile as a CBD-focused health and wellness innovator as it continues to acquire other promising industry players. The passage of the U.S. Farm Bill in 2018 drove a fiercely competitive market for hemp-based CBD but a significant decline in the market during the past year’s pandemic has driven a consolidation of brands. HempFusion recently completed full acquisition of Sagely Enterprises Inc. (“Sagely Naturals”), which will boost HempFusion’s retail channel by 14,000 outlets. CBD remains a go-to option for many Americans seeking relief from post-workout soreness and relaxation. HempFusion’s OTC topicals are designed to meet consumer…

Continue Reading

ThursdayJul 15, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Commercial Success with its Drug Delivery Technology

Lexaria is making progress with research on its DehydraTECH drug delivery technology Advanced 2nd-generation DehydraTECH 2.0 formulations utilized in ongoing hypertension studies The company intends to monetize its technology for commercial use  Its quest for commercial success also follows its move to delist from the Canada Securities Exchange (“CSE”) to focus on the Nasdaq listing Lexaria Bioscience (NASDAQ: LEXX) continues to innovate with its DehydraTECH(TM) drug-delivery technology. It is constantly collaborating with research institutions and businesses to identify other new ways to improve its technology. So far, advanced DehydraTECH 2.0 formulations are already being used by the company in ongoing…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722